Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 9, 2016, Pages 1640-1649

  Balogh, Eniko ^a   Tolnai, Emese ^a   Nagy, Béla ^a,a   Balla, György ^a   Balla, József ^a   Jeney, Viktória ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Ferritin; Human mesenchymal stem cell; Iron; Osteogenic differentiation; Runx2

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; FERRITIN; IRON; MESSENGER RNA; OSTEOCALCIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE REMODELING; CELL DIFFERENTIATION; CHONDROGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; IN VITRO STUDY; IRON OVERLOAD; MALE; MESENCHYMAL STEM CELL; MINERALIZATION; MOUSE; NONHUMAN; OSTEOPROGENITOR CELL; PRIORITY JOURNAL; UPREGULATION;

EID: 84973487274     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2016.06.003     Document Type: Article

References (51)

1. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25(11):2739-2749.
2. James A.W. Review of signaling pathways governing MSC osteogenic and adipogenic differentiation. Scientifica 2013, 2013:684736.
3. Franceschi R.T., Xiao G., Jiang D., Gopalakrishnan R., Yang S., Reith E. Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation. Connect. Tissue Res. 2003, 44(Suppl. 1):109-116.
4. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89(5):765-771.
5. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89(5):755-764.
6. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89(5):747-754.
7. Atashi F., Modarressi A., Pepper M.S. The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: a review. Stem Cells Dev. 2015, 24(10):1150-1163.
8. Angelopoulos N.G., Goula A.K., Papanikolaou G., Tolis G. Osteoporosis in HFE2 juvenile hemochromatosis. A case report and review of the literature. Osteoporos. Int. 2006, 17(1):150-155.
9. Valenti L., Varenna M., Fracanzani A.L., Rossi V., Fargion S., Sinigaglia L. Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos. Int. 2009, 20(4):549-555.
10. Guggenbuhl P., Deugnier Y., Boisdet J.F., Rolland Y., Perdriger A., Pawlotsky Y., et al. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos. Int. 2005, 16(12):1809-1814.
11. Sinigaglia L., Fargion S., Fracanzani A.L., Binelli L., Battafarano N., Varenna M., et al. Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J. Rheumatol. 1997, 24(9):1809-1813.
12. Tsay J., Yang Z., Ross F.P., Cunningham-Rundles S., Lin H., Coleman R., et al. Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood 2010, 116(14):2582-2589.
13. Kudo H., Suzuki S., Watanabe A., Kikuchi H., Sassa S., Sakamoto S. Effects of colloidal iron overload on renal and hepatic siderosis and the femur in male rats. Toxicology 2008, 246(2-3):143-147.
14. Guggenbuhl P., Fergelot P., Doyard M., Libouban H., Roth M.P., Gallois Y., et al. Bone status in a mouse model of genetic hemochromatosis. Osteoporos. Int. 2011, 22(8):2313-2319.
15. Ganz T. Systemic iron homeostasis. Physiol. Rev. 2013, 93(4):1721-1741.
16. Sun L., Guo W., Yin C., Zhang S., Qu G., Hou Y., et al. Hepcidin deficiency undermines bone load-bearing capacity through inducing iron overload. Gene 2014, 543(1):161-165.
17. Puntarulo S. Iron, oxidative stress and human health. Mol. Asp. Med. 2005, 26(4-5):299-312.
18. Harrison P.M., Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1996, 1275(3):161-203.
19. Theil E.C. Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu. Rev. Biochem. 1987, 56:289-315.
20. Rucker P., Torti F.M., Torti S.V. Role of H and L subunits in mouse ferritin. J. Biol. Chem. 1996, 271(52):33352-33357.
21. Yoshino Y., Manis J., Schachter D. Regulation of ferritin synthesis in rat liver. J. Biol. Chem. 1968, 243(11):2911-2917.
22. Hentze M.W., Rouault T.A., Caughman S.W., Dancis A., Harford J.B., Klausner R.D. A cis-acting element is necessary and sufficient for translational regulation of human ferritin expression in response to iron. Proc. Natl. Acad. Sci. U. S. A. 1987, 84(19):6730-6734.
23. Casey J.L., Hentze M.W., Koeller D.M., Caughman S.W., Rouault T.A., Klausner R.D., et al. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science 1988, 240(4854):924-928.
24. Jia P., Xu Y.J., Zhang Z.L., Li K., Li B., Zhang W., et al. Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species. J. Orthop. Res. 2012, 30(11):1843-1852.
25. Nouraie M., Cheng K., Niu X., Moore-King E., Fadojutimi-Akinsi M.F., Minniti C.P., et al. Predictors of osteoclast activity in patients with sickle cell disease. Haematologica 2011, 96(8):1092-1098.
26. Zarjou A., Jeney V., Arosio P., Poli M., Zavaczki E., Balla G., et al. Ferritin ferroxidase activity: a potent inhibitor of osteogenesis. J. Bone Miner. Res. 2010, 25(1):164-172.
27. Maes C., Kobayashi T., Selig M.K., Torrekens S., Roth S.I., Mackem S., et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev. Cell 2010, 19(2):329-344.
28. Dalle Carbonare L., Valenti M.T., Zanatta M., Donatelli L., Lo C.V. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum. 2009, 60(11):3356-3365.
29. Zhu H., Guo Z.K., Jiang X.X., Li H., Wang X.Y., Yao H.Y., et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat. Protoc. 2010, 5(3):550-560.
30. Jeney V., Balla J., Yachie A., Varga Z., Vercellotti G.M., Eaton J.W., et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood 2002, 100(3):879-887.
31. Zarjou A., Jeney V., Arosio P., Poli M., Antal-Szalmas P., Agarwal A., et al. Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. J. Am. Soc. Nephrol. 2009, 20(6):1254-1263.
32. Jaiswal N., Haynesworth S.E., Caplan A.I., Bruder S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem. 1997, 64(2):295-312.
33. Shanahan C.M., Crouthamel M.H., Kapustin A., Giachelli C.M. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ. Res. 2011, 109(6):697-711.
34. Siddappa R., Fernandes H., Liu J., van Blitterswijk C., de Boer J. The response of human mesenchymal stem cells to osteogenic signals and its impact on bone tissue engineering. Curr. Stem Cell Res. Ther. 2007, 2(3):209-220.
35. Laeng H., Egger T., Roethlisberger C., Cottier H. Stainable bone iron in undecalcified, plastic-embedded sections. Occurrence in man related to the presence of "free" iron?. Am. J. Pathol. 1988, 131(2):344-350.
36. Basle M.F., Mauras Y., Audran M., Clochon P., Rebel A., Allain P. Concentration of bone elements in osteoporosis. J. Bone Miner. Res. 1990, 5(1):41-47.
37. Ebrahimpour L., Akhlaghpoor S., Azarkayvan A., Salehi M., Morteza A., Alinaghi R. Correlation between bone mineral densitometry and liver/heart iron overload evaluated by quantitative T2* MRI. Hematology 2012, 17(5):297-301.
38. de Vernejoul M.C., Pointillart A., Golenzer C.C., Morieux C., Bielakoff J., Modrowski D., et al. Effects of iron overload on bone remodeling in pigs. Am. J. Pathol. 1984, 116(3):377-384.
39. Matsushima S., Hoshimoto M., Torii M., Ozaki K., Narama I. Iron lactate-induced osteopenia in male Sprague-Dawley rats. Toxicol. Pathol. 2001, 29(6):623-629.
40. Frost H.M. Tetracycline-based histological analysis of bone remodeling. Calcif. Tissue Res. 1969, 3(3):211-237.
41. Vaananen H.K., Laitala-Leinonen T. Osteoclast lineage and function. Arch. Biochem. Biophys. 2008, 473(2):132-138.
42. Hofbauer L.C., Kuhne C.A., Viereck V. The OPG/RANKL/RANK system in metabolic bone diseases. J. Musculoskelet. Nueronal Interact. 2004, 4(3):268-275.
43. Morabito N., Gaudio A., Lasco A., Atteritano M., Pizzoleo M.A., Cincotta M., et al. Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle. J. Bone Miner. Res. 2004, 19(5):722-727.
44. Hou J.M., Xue Y., Lin Q.M. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway. Acta Pharmacol. Sin. 2012, 33(10):1277-1284.
45. Yamasaki K., Hagiwara H. Excess iron inhibits osteoblast metabolism. Toxicol. Lett. 2009, 191(2-3):211-215.
46. Gimble J.M., Nuttall M.E. The relationship between adipose tissue and bone metabolism. Clin. Biochem. 2012, 45(12):874-879.
47. Kao C.L., Tai L.K., Chiou S.H., Chen Y.J., Lee K.H., Chou S.J., et al. Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev. 2010, 19(2):247-258.
48. Chen C.T., Shih Y.R., Kuo T.K., Lee O.K., Wei Y.H. Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 2008, 26(4):960-968.
49. Arosio P., Ingrassia R., Cavadini P. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim. Biophys. Acta 2009, 1790(7):589-599.
50. Yang N.D., Tan S.H., Ng S., Shi Y., Zhou J., Tan K.S., et al. Artesunate induces cell death in human cancer cells via enhancing lysosomal function and lysosomal degradation of ferritin. J. Biol. Chem. 2014, 289(48):33425-33441.
51. Watt R.K. The many faces of the octahedral ferritin protein. Biometals 2011, 24(3):489-500.